Results 21 to 30 of about 656 (115)

Reimbursement of the PET in oncology in Europe: a questionnaire based survey

, 2003
SummaryAim: The discussion in Germany about the reimbursement of the 18F-fluorodeoxyglucose Positron-Emissiontomography (FDG-PET) in oncology should make use of the experience from the other European countries.
M. Dietlein, H. Schicha
core   +1 more source

Blood-Brain Barrier Penetration of Zolmitriptan—Modelling of Positron Emission Tomography Data [PDF]

, 2018
Positron emissiontomography (PET) with the drug radiolabelled allows a direct measurement of brain or other organ kinetics, information which can be essential in drug development.
Bergström, Mats, Långström, Bengt, Yates, Roger, Syvänen, Stina, Wall, Anders, Kågedal, Matts   +5 more
core  

HF ultrasound vs PET-CT and telethermography in the diagnosis of In-transit metastases frommelanoma: a prospective study and review of the literature [PDF]

, 2014
Background Over the past several years the incidence of cutaneous melanoma has rapidly increased. This tumor develops often in-transit metastases that significantly reduce patient survival at 5 years. To improve prognosis and quality of life in patients
Francesco Solivetti, S. Di Filippo, Antonio Bonadies, Isabella Sperduti, F. M. Solivetti, A. Di Carlo, Flora Desiderio, Simona Di Filippo, Carlo Maini, A. Guerrisi, I. Sperduti, A. Bonadies, C. Ludovico, Valerio D¿Orazi, F. Desiderio, Aldo Di Carlo, Carlo Ludovico Maini, Valerio D’Orazi, D'ORAZI, VALERIO, Francesco Maria Solivetti, Antonino Guerrisi   +20 more
core   +1 more source

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. [PDF]

, 2013
© Queen’s Printer and Controller of HMSO 2013. This work was produced by Meads et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
Meads, C., P Barton, P Guest, C Davenport, Borowiack, E., Khan, K., Thangaratinam, S, Martin-Hirsch, P., Sundar, S.; id_orcid, Zapalska, A., Guest, Peter, Thangaratinam, S.; id_orcid, Barton, P., C Meads, T Roberts, Kowalska, M., P Auguste, Małysiak, S, M Kowalska, A Zapalska, Khan, K, S Sundar, S Thangaratinam, Meads, C, Roberts, T., Davenport, C, Sundar, S, Barton, P, Auguste, P., Kowalska, M, Guest, P, P Martin-Hirsch, Martin-Hirsch, P, Davenport, C.; id_orcid, S Małysiak, Zapalska, A, Roberts, T, E Borowiack, Auguste, P, Małysiak, S., K Khan, Borowiack, E   +41 more
core   +1 more source

Evaluation of a silicon photomultiplier PET insert for simultaneous PET and MR imaging

, 2016
Purpose: In this study, the authors present a silicon photomultiplier (SiPM)-based positron emissiontomography (PET) insert dedicated to small animal imaging with high system performance androbustness to temperature change.
Ko, Guen Bae, Im, Hyung-Jun, Yoon, Hyun Suk, Lee, Jae Sung, Kim, Kyeong Yun, Lee, Min Sun, Son, Jeong-Whan   +6 more
core   +1 more source

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure [PDF]

, 2008
This is a pre-print of an article published in Leukemia and Lymphoma 2007 published by Taylor & Francis. This version is reproduced under the journals author licence agreement.
Ng, Ashley P., SEYMOUR, JOHN, Hogg, Annette, MACMANUS, MICHAEL, Hicks, Rodney J., Prince, H Miles, Lee, Michael, WIRTH, ANDREW, JANUSZEWICZ, HENRY, WOLF, MIECZYSLAW   +9 more
core  

Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues

, 2011
Background. Mammalian target of rapamycin inhibitor everolimus administered to four insulinoma patients rapidly controlled hypoglycemia (Kulke et al., N Engl JMed 2009; 360: 195-197).
de Vries, Elisabeth G. E.; id_orcid, Links, Thera P., Wouter S. Remkes, Ester J.M. Siemerink, Remkes, Wouter S., Helle-Brit Fiebrich, Elisabeth G. E. Vries, Brouwers, Adrienne H., Hospers, Geke A. P., de Vries, Elisabeth G. E., Adrienne H. Brouwers, Fiebrich, Helle-Brit, Brouwers, Adrienne H.; id_orcid, Siemerink, Ester J. M., Geke A.P. Hospers, Thera P. Links   +15 more
core   +1 more source

DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS

, 2022
Background and AimsRelapsed or refractory (R/R) high-risk (HR) neuroblastoma (NB) has a dismalprognosis. Anti-GD2-mediated chemo-immunotherapy has a considerable anti-tumoractivity in patients with R/R HR-NB.
Kızmazoğlu, Deniz, Çetingöz, Emrullah Rıza, Önal, Ayşe, Altun, Zekiye Sultan, Özer, Erdener, Çeçen, Refik Emre, Aktaş, Safiye, Demiral, Ayşe Nur, Olgun, Hatice Nur, İnce, Dilek, Baysal, Birsen, Özdoğan, Özhan, Güleryüz Uçar, Handan, Kamer, Emine Serra, Çelik, Ahmet, Olguner, Mustafa   +15 more
core  

Coal worker’s pneumoconiosis and sarcoid-like reaction mimicking lymph node metastases in a patient with lung cancer: A case report

, 2017
Sarcoid-like reactions occur in a small percentage of cancer patients. This reaction causeslymph nodes to appear hypermetabolic when viewed with Fludeoxyglucose-Positron EmissionTomography (FDG-PET).
Chad Duncan, Lukman Tijani, Suzanne Graham, Cynthia Jumper, Ruc Tran   +4 more
core   +1 more source

18F-Labelled inhibitors for targeting of IDH1 mutant gliomas

, 2023
Objectives: Low grade diffuse gliomas are primary brain tumorscharacterized by the presence of mutations in isocitrate dehydrogen-ase 1 (IDH1), which equip the enzyme with a neomorphic activity thatincreases production of 2-hydroxyglutarate [1].
Bier, Dirk, Neumaier, Bernd, Cologni, Roberta, Holschbach, Marcus, Carloni, Paolo   +4 more
core